Skip to content

Scholar Rock SRRK Change in AP

Change in AP at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
-$68.71M-471%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-$11.81M-42.2%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$4.24M+98.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$7.17M-141%
Arrowhead Research logo
Arrowhead ResearchARWR
$15.26M+397%
Roivant Sciences logo
Roivant SciencesROIV
$16.16M+9,891%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's change in AP?
Scholar Rock (SRRK) reported change in AP of -$1.09M in Q1 2026.
How has Scholar Rock's change in AP changed year-over-year?
Scholar Rock's change in AP increased by 80.8% year-over-year, from -$5.66M to -$1.09M.
What is the long-term trend for Scholar Rock's change in AP?
Over 2 years (2021 to 2025), Scholar Rock's change in AP has grown at a -54.8% compound annual growth rate (CAGR), from $1.02M to $208K.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.